Md Rashed-Al-Mahfuz1, Abedul Haque2, Akm Azad3, Salem A Alyami4, Julian M W Quinn5, Mohammad Ali Moni6. 1. Department of Computer Science and EngineeringUniversity of RajshahiRajshahi6205Bangladesh. 2. Department of HematopathologyThe University of Texas MD Anderson Cancer CenterHoustonTX77030USA. 3. iThree Institute, University of Technology SydneyNSW2007Australia. 4. Department of Mathematics and StatisticsImam Muhammad Ibn Saud Islamic UniversityRiyadh13318Saudi Arabia. 5. Bone Biology DivisionGarvan Institute of Medical ResearchDarlinghurstNSW2010Australia. 6. WHO Collaborating Centre of eHealth, School of Public Health and Community MedicineUniversity of New South WalesSydneyNSW2052Australia.
Abstract
OBJECTIVE: Chronic kidney disease (CKD) is a major public health concern worldwide. High costs of late-stage diagnosis and insufficient testing facilities can contribute to high morbidity and mortality rates in CKD patients, particularly in less developed countries. Thus, early diagnosis aided by vital parameter analytics using affordable computer-aided diagnosis could not only reduce diagnosis costs but improve patient management and outcomes. METHODS: In this study, we developed machine learning models using selective key pathological categories to identify clinical test attributes that will aid in accurate early diagnosis of CKD. Such an approach will save time and costs for diagnostic screening. We have also evaluated the performance of several classifiers with k-fold cross-validation on optimized datasets derived using these selected clinical test attributes. RESULTS: Our results suggest that the optimized datasets with important attributes perform well in diagnosis of CKD using our proposed machine learning models. Furthermore, we evaluated clinical test attributes based on urine and blood tests along with clinical parameters that have low costs of acquisition. The predictive models with the optimized and pathologically categorized attributes set yielded high levels of CKD diagnosis accuracy with random forest (RF) classifier being the best performing. CONCLUSIONS: Our machine learning approach has yielded effective predictive analytics for CKD screening which can be developed as a resource to facilitate improved CKD screening for enhanced and timely treatment plans.
OBJECTIVE: Chronic kidney disease (CKD) is a major public health concern worldwide. High costs of late-stage diagnosis and insufficient testing facilities can contribute to high morbidity and mortality rates in CKD patients, particularly in less developed countries. Thus, early diagnosis aided by vital parameter analytics using affordable computer-aided diagnosis could not only reduce diagnosis costs but improve patient management and outcomes. METHODS: In this study, we developed machine learning models using selective key pathological categories to identify clinical test attributes that will aid in accurate early diagnosis of CKD. Such an approach will save time and costs for diagnostic screening. We have also evaluated the performance of several classifiers with k-fold cross-validation on optimized datasets derived using these selected clinical test attributes. RESULTS: Our results suggest that the optimized datasets with important attributes perform well in diagnosis of CKD using our proposed machine learning models. Furthermore, we evaluated clinical test attributes based on urine and blood tests along with clinical parameters that have low costs of acquisition. The predictive models with the optimized and pathologically categorized attributes set yielded high levels of CKD diagnosis accuracy with random forest (RF) classifier being the best performing. CONCLUSIONS: Our machine learning approach has yielded effective predictive analytics for CKD screening which can be developed as a resource to facilitate improved CKD screening for enhanced and timely treatment plans.
Authors: Adrienne S Allen; John P Forman; E John Orav; David W Bates; Bradley M Denker; Thomas D Sequist Journal: J Gen Intern Med Date: 2010-10-05 Impact factor: 5.128
Authors: Anima Singh; Girish Nadkarni; Omri Gottesman; Stephen B Ellis; Erwin P Bottinger; John V Guttag Journal: J Biomed Inform Date: 2014-11-15 Impact factor: 6.317
Authors: Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman Journal: Am J Kidney Dis Date: 2014-03-16 Impact factor: 8.860
Authors: Laura C Plantinga; L Ebony Boulware; Josef Coresh; Lesley A Stevens; Edgar R Miller; Rajiv Saran; Kassandra L Messer; Andrew S Levey; Neil R Powe Journal: Arch Intern Med Date: 2008-11-10
Authors: Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst Journal: Kidney Int Date: 2015-03-04 Impact factor: 10.612